Skip to content

Effects of propofol and propofol on acute kidney injury after robot-assisted laparoscopic partial nephrectomy : a randomized, double-blind, controlled trial

Effects of propofol and propofol on acute kidney injury after robot-assisted laparoscopic partial nephrectomy : a randomized, double-blind, controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119086
Enrollment
Unknown
Registered
2026-02-14
Start date
2026-02-18
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal massive lesions

Interventions

Cyclopophenol group:General anesthesia was induced with propofol ( 0.4mg / kg ), sufentanil, midazolam and cisatracurium. After successful induction of anesthesia, after the patient 's muscle relaxati
Propofol group:General anesthesia was induced by propofol ( 2mg / kg ), sufentanil, midazolam and cisatracurium. After successful induction of anesthesia, after the patient 's muscle relaxation and un

Sponsors

first affiliated hospital of anhui medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. patients undergoing elective robotic-assisted laparoscopic partial nephrectomy; 2. Age 20-80 years; 3. American Society of Anaesthesiologists ASA Class I-III; 4. No history of long-term use of analgesic, sedative or anxiolytic drugs; 5. Informed consent, voluntary participation in the trial, and signing the informed consent form. 6. All patients who meet the inclusion criteria will be informed in detail of the purpose of the study, the rights and obligations of the patients, and sign the informed consent form according to their wishes.

Exclusion criteria

Exclusion criteria: 1. patient refusal; 2. pregnancy or breastfeeding; 3. allergy to propofol or cypropofol; 4. patients who have undergone kidney transplantation 5. subjects who, in the opinion of the investigator, should not participate in this study;

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative AKI;

Secondary

MeasureTime frame
Postoperative estimated glomerular filtration rate;serum cystatin c;serum creatinine level;Anesthetic consumption;operation time;duration of anesthesia;Use of vasoactive drugs;Postoperative quality of life score;Perioperative adverse events occurred;hospital stay after operation;systemic immune-inflammation index;lymphocyte to neutrophil ratio;Urine volume during anesthesia;

Countries

China

Contacts

Public ContactXu Guanghong

first affiliated hospital of anhui medical university

yfy102901@fy.ahmu.edu.cn+86 138 5694 9535

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026